Population health management in Belgium: a call-to-action and case study.

Atherosclerotic cardiovascular disease Barriers Belgium Implementation Lessons Population health management

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
20 Jun 2023
Historique:
received: 27 09 2022
accepted: 31 05 2023
medline: 22 6 2023
pubmed: 21 6 2023
entrez: 20 6 2023
Statut: epublish

Résumé

Although there are already success stories, population health management in Belgium is still in its infancy. A health system transformation approach such as population health management may be suited to address the public health issue of atherosclerotic cardiovascular disease, as this is one of the main causes of mortality in Belgium. This article aims to raise awareness about population health management in Belgium by: (a) eliciting barriers and recommendations for its implementation as perceived by local stakeholders; (b) developing a population health management approach to secondary prevention of atherosclerotic cardiovascular disease; and (c) providing a roadmap to introduce population health management in Belgium. Two virtual focus group discussions were organized with 11 high-level decision makers in medicine, policy and science between October and December 2021. A semi-structured guide based on a literature review was used to anchor discussions. These qualitative data were studied by means of an inductive thematic analysis. Seven inter-related barriers and recommendations towards the development of population health management in Belgium were identified. These related to responsibilities of different layers of government, shared responsibility for the health of the population, a learning health system, payment models, data and knowledge infrastructure, collaborative relationships and community involvement. The introduction of a population health management approach to secondary prevention of atherosclerotic cardiovascular disease may act as a proof-of-concept with a view to roll out population health management in Belgium. There is a need to instill a sense of urgency among all stakeholders to develop a joint population-oriented vision in Belgium. This call-to-action requires the support and active involvement of all Belgian stakeholders, both at the national and regional level.

Sections du résumé

BACKGROUND BACKGROUND
Although there are already success stories, population health management in Belgium is still in its infancy. A health system transformation approach such as population health management may be suited to address the public health issue of atherosclerotic cardiovascular disease, as this is one of the main causes of mortality in Belgium. This article aims to raise awareness about population health management in Belgium by: (a) eliciting barriers and recommendations for its implementation as perceived by local stakeholders; (b) developing a population health management approach to secondary prevention of atherosclerotic cardiovascular disease; and (c) providing a roadmap to introduce population health management in Belgium.
METHODS METHODS
Two virtual focus group discussions were organized with 11 high-level decision makers in medicine, policy and science between October and December 2021. A semi-structured guide based on a literature review was used to anchor discussions. These qualitative data were studied by means of an inductive thematic analysis.
RESULTS RESULTS
Seven inter-related barriers and recommendations towards the development of population health management in Belgium were identified. These related to responsibilities of different layers of government, shared responsibility for the health of the population, a learning health system, payment models, data and knowledge infrastructure, collaborative relationships and community involvement. The introduction of a population health management approach to secondary prevention of atherosclerotic cardiovascular disease may act as a proof-of-concept with a view to roll out population health management in Belgium.
CONCLUSIONS CONCLUSIONS
There is a need to instill a sense of urgency among all stakeholders to develop a joint population-oriented vision in Belgium. This call-to-action requires the support and active involvement of all Belgian stakeholders, both at the national and regional level.

Identifiants

pubmed: 37340416
doi: 10.1186/s12913-023-09626-x
pii: 10.1186/s12913-023-09626-x
pmc: PMC10283319
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

659

Informations de copyright

© 2023. The Author(s).

Références

N Engl J Med. 2014 Oct 30;371(18):1704-14
pubmed: 25354104
Med Care. 2016 Nov;54(11):970-976
pubmed: 27479592
Int J Integr Care. 2021 Oct 29;21(4):8
pubmed: 34754284
Int J Health Policy Manag. 2021 Jul 06;:
pubmed: 34273935
Health Aff (Millwood). 2018 Jan;37(1):30-37
pubmed: 29309220
Health Aff (Millwood). 2008 May-Jun;27(3):759-69
pubmed: 18474969
N Engl J Med. 2016 Jan 7;374(1):8-11
pubmed: 26731305
Health Aff (Millwood). 2016 Nov 1;35(11):2109-2115
pubmed: 27834253
J Health Serv Res Policy. 2020 Jul;25(3):187-201
pubmed: 32178546
Health Syst Transit. 2020 Dec;22(5):1-237
pubmed: 33527904
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
Milbank Q. 2012 Sep;90(3):421-56
pubmed: 22985277
Health Policy. 2020 Jan;124(1):37-43
pubmed: 31806356
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
J Health Organ Manag. 2018 Apr 9;32(2):224-245
pubmed: 29624140
Int J Health Policy Manag. 2022 Mar 15;:
pubmed: 35297240
Health Policy. 2015 Apr;119(4):522-9
pubmed: 25516015
Health Aff (Millwood). 2018 Apr;37(4):579-584
pubmed: 29608349
Popul Health Manag. 2017 Feb;20(1):74-85
pubmed: 27124406
J Res Nurs. 2020 Dec;25(8):652-661
pubmed: 34394687
BMC Health Serv Res. 2018 Apr 13;18(1):285
pubmed: 29653537

Auteurs

Betty Steenkamer (B)

Stichting Gezondheidscentra Eindhoven - STROOMZ NL, Eindhoven, the Netherlands.

Bert Vaes (B)

Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Ernst Rietzschel (E)

Department of Internal Medicine & Paediatrics, Ghent University, Ghent, Belgium.
Biobanking and Cardiovascular Prevention, Ghent University Hospital, Ghent, Belgium.

John Crombez (J)

Architecture of a Qualitative, Sustainable and Inclusive Health system (AQSIH), Ghent University Hospital, Ghent, Belgium.

Sabina De Geest (S)

Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Department of Public Health, University of Basel, Basel, Switzerland.

Fabian Demeure (F)

Cardiology Department, CHU UCL Mont-Godinne, Namur, Belgium.

Marijke Gielen (M)

Independent Health Insurance Funds, Brussels, Belgium.

Michel P Hermans (MP)

Endocrinology & Nutrition, Cliniques universitaires St-Luc, Brussels, Belgium.
Medical School, Catholic University of Louvain, Brussels, Belgium.

Stefan Teughels (S)

Domus Medica, Antwerp, Belgium.

Peter Vanacker (P)

Department of Neurology, AZ Groeninge, Kortrijk, Belgium.
Department of Neurology, University Hospitals Antwerp, Antwerp, Belgium.
Department of Translational Neuroscience, University of Antwerp, Antwerp, Belgium.

Thierry van der Schueren (T)

Société Scientifique de Médecine Générale, Brussels, Belgium.

Steven Simoens (S)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. steven.simoens@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH